Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ICCC
#3453
Immucell Corp
6.4
0
+0.79%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+0.79%
Monthly Change
+0.63%
6 month change
+4.40%
Cambio anual
+21.67%
Cierres anteriores
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
Volumen
3
Markets
Acciones
Atención Sanitaria
ICCC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
8.91 M
8.98 M
9.04 M
9.05 M
9.05 M
—
Valuation ratios
Enterprise value
32.1 M
46.01 M
43.04 M
62.71 M
52.65 M
204.41 M
Price to earnings ratio
-7.26
-19.81
-119.75
31.64
21.55
-86.37
Price to sales ratio
1.2
1.59
1.46
2.11
1.97
7.13
Price to cash flow ratio
-84.13
117.52
28
25.41
28.22
199.16
Price to book ratio
0.29
1.53
0.37
0.53
0.47
2.9
Enterprise value to EBITDA ratio
18.44
42.22
17.01
13.98
10.32
83.53
Profitability ratios
Return on assets %
-0.02
0.01
0.03
0.01
-0
0.05
Return on equity %
-0.03
0.02
0.05
0.02
-0
0.08
Return on invested capital %
-5.78
5.85
10.41
5.2
0.2
21.66
Gross margin %
26.34
36.53
41.58
43.72
42.92
164.75
Operating margin %
-9.56
8.02
13.85
8.84
0.36
31.07
EBITDA margin %
1.85
17.03
22.37
19.37
13.24
72.01
Net margin %
-11.67
6.64
17.94
7.79
-2.54
29.82
Liquidity ratios
Quick ratio
1.44
1.8
2.21
1.99
1.76
7.76
Current ratio
3.11
3.41
4.12
3.85
4.21
15.59
Inventory turnover
0.6
0.68
0.65
0.46
—
—
Asset turnover
0.14
0.17
0.18
0.14
0.12
0.61
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.23
0.22
0.18
0.17
0.81
Long term debt to total equity ratio
0.41
0.38
0.35
0.28
0.27
1.28
Per share metrics
Operating cash flow per share
-0.08
-0
0.18
0.18
-0.13
0.22
EBIT per share
-0.07
0.08
0.12
0.06
0
0.27
EBITDA per share
0.01
0.16
0.2
0.14
0.08
0.58
Total debt per share
—
—
—
—
—
—
Cash per share
0.03
0.03
0.03
0.03
0.43
0.52
Net current asset value per share
1.7
1.84
1.77
1.9
1.86
7.37
Tangible book value per share
3.22
3.36
3.22
3.3
3.28
13.15
Working capital per share
1.15
1.3
1.34
1.41
1.42
5.47
Book value per share
3.23
3.37
3.23
3.31
3.29
13.2
Noticias
Des administrateurs d’ImmuCell se retireront lors de l’assemblée annuelle de 2026
ImmuCell directors to step down at 2026 annual meeting, board changes expected
ImmuCell annonce de nouveaux contrats de travail pour ses dirigeants et des attributions d’options
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
Transcription de l’alerte résultats : ImmuCell au T4 2025 voit un mouvement positif de l’action
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
ImmuCell annonce des ventes de 7,6 millions € au T4 et réoriente sa stratégie
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell met en pause Re-Tain après une lettre de la FDA | Benzinga France
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)